Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 50034576
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364484(CHEMBL1950864)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364484(CHEMBL1950864)
Affinity DataEC50:  5nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364500(CHEMBL1950850)
Affinity DataIC50: 18nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364499(CHEMBL1950851)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364495(CHEMBL1950855)
Affinity DataIC50: 24nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364494(CHEMBL1950856)
Affinity DataIC50: 24nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364508(CHEMBL1950842)
Affinity DataIC50: 26nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364493(CHEMBL1950857)
Affinity DataIC50: 30nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364491(CHEMBL1950859)
Affinity DataIC50: 32nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364502(CHEMBL1950848)
Affinity DataIC50: 33nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364486(CHEMBL1949685)
Affinity DataIC50: 40nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364492(CHEMBL1950858)
Affinity DataIC50: 42nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364507(CHEMBL1950843)
Affinity DataIC50: 44nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364490(CHEMBL1950860)
Affinity DataIC50: 49nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364498(CHEMBL1950852)
Affinity DataIC50: 50nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364497(CHEMBL1950853)
Affinity DataIC50: 52nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364500(CHEMBL1950850)
Affinity DataEC50:  58nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364493(CHEMBL1950857)
Affinity DataEC50:  60nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364491(CHEMBL1950859)
Affinity DataEC50:  60nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364499(CHEMBL1950851)
Affinity DataEC50:  60nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364506(CHEMBL1950844)
Affinity DataIC50: 62nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364492(CHEMBL1950858)
Affinity DataEC50:  68nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364501(CHEMBL1950849)
Affinity DataIC50: 68nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364494(CHEMBL1950856)
Affinity DataEC50:  71nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364509(CHEMBL1950841)
Affinity DataIC50: 80nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364496(CHEMBL1950854)
Affinity DataIC50: 90nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364502(CHEMBL1950848)
Affinity DataEC50:  104nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364486(CHEMBL1949685)
Affinity DataEC50:  113nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364487(CHEMBL1950863)
Affinity DataIC50: 115nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364495(CHEMBL1950855)
Affinity DataEC50:  117nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364512(CHEMBL1950730)
Affinity DataIC50: 130nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364498(CHEMBL1950852)
Affinity DataEC50:  156nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364496(CHEMBL1950854)
Affinity DataEC50:  158nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364497(CHEMBL1950853)
Affinity DataEC50:  164nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364487(CHEMBL1950863)
Affinity DataEC50:  185nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364510(CHEMBL1950732)
Affinity DataIC50: 270nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364501(CHEMBL1950849)
Affinity DataEC50:  279nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetE3 ubiquitin-protein ligase XIAP(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364485(CHEMBL1950720)
Affinity DataIC50: 280nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of XIAP using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364490(CHEMBL1950860)
Affinity DataEC50:  300nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364489(CHEMBL1950861)
Affinity DataIC50: 301nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetE3 ubiquitin-protein ligase XIAP(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364484(CHEMBL1950864)
Affinity DataIC50: 365nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of XIAP using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364489(CHEMBL1950861)
Affinity DataEC50: >370nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364488(CHEMBL1950862)
Affinity DataEC50: >370nMAssay Description:Antagonist activity at cIAP1 in human MDA-MB-231 cells assessed as cIAP1 degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364511(CHEMBL1950731)
Affinity DataIC50: 450nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364520(CHEMBL1950722)
Affinity DataIC50: 500nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364488(CHEMBL1950862)
Affinity DataIC50: 593nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364519(CHEMBL1950723)
Affinity DataIC50: 740nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364516(CHEMBL1950726)
Affinity DataIC50: 740nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364517(CHEMBL1950725)
Affinity DataIC50: 780nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50364514(CHEMBL1950728)
Affinity DataIC50: 790nMAssay Description:Antagonist activity at GST-tagged BIR3 domain of cIAP1 using AbuRPFK-5FAM after 20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: